Paper32102432
N-(2-Hydroxyphenyl)-1-[3-(2-oxo-2,3-dihydro-1H- benzimidazol-1-yl)propyl]piperidine-4-Carboxamide (D2AAK4), a Multi-Target Ligand of Aminergic GPCRs, as a Potential Antipsychotic.
Kaczor AA and 5 others. Biomolecules, 2020. Cited by 12 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. N-(2-Hydroxyphenyl)-1-[3-(2-oxo-2,3-dihydro-1H- benzimidazol-1-yl)propyl]piperidine-4-Carboxamide (D2AAK4), a Multi-Target Ligand of Aminergic GPCRs, as a Potential Antipsychotic. Papers, record 32102432. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32102432
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- N-(2-Hydroxyphenyl)-1-[3-(2-oxo-2,3-dihydro-1H- benzimidazol-1-yl)propyl]piperidine-4-Carboxamide (D2AAK4), a Multi-Target Ligand of Aminergic GPCRs, as a Potential Antipsychotic.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Piperidines | Major topic |
| Animals | |
| Antipsychotic Agents | |
| Drug Design | |
| Humans | |
| Ligands | |
| Models, Molecular | |
| Receptors, G-Protein-Coupled | |
| Schizophrenia | |
| Structure-Activity Relationship |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2017/27/B/NZ7/01767 | Narodowe Centrum Nauki | International | PubMed | |
| SAF2014-57138-C2-1-R | Ministerio de Economía, Industria y Competitividad, Gobierno de España | International | PubMed |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17,548,746 | Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. | Arch Gen Psychiatry | 2007 | https://conductscience.org/library/papers/17548746 | PubMed |
| 2 | 24,631,727 | Novel insights on the structural determinants of clozapine and olanzapine multi-target binding profiles. | Eur J Med Chem | 2014 | https://conductscience.org/library/papers/24631727 | PubMed |
| 3 | 24,677,189 | The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review. | CNS Drugs | 2014 | https://conductscience.org/library/papers/24677189 | PubMed |
| 4 | 24,794,100 | Role of atypical antipsychotics in the treatment of generalized anxiety disorder. | CNS Drugs | 2014 | https://conductscience.org/library/papers/24794100 | PubMed |
| 5 | 18,465,762 | Multi-receptor binding profile of clozapine and olanzapine: a structural study based on the new beta2 adrenergic receptor template. | ChemMedChem | 2008 | https://conductscience.org/library/papers/18465762 | PubMed |
| 6 | 19,922,537 | Phe369(7.38) at human 5-HT(7) receptors confers interspecies selectivity to antagonists and partial agonists. | Br J Pharmacol | 2010 | https://conductscience.org/library/papers/19922537 | PubMed |
| 7 | 25,806,997 | Multi-Step Protocol for Automatic Evaluation of Docking Results Based on Machine Learning Methods--A Case Study of Serotonin Receptors 5-HT(6) and 5-HT(7). | J Chem Inf Model | 2015 | https://conductscience.org/library/papers/25806997 | PubMed |
| 8 | 30,723,326 | Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine. | Nat Struct Mol Biol | 2019 | https://conductscience.org/library/papers/30723326 | PubMed |
| 9 | 31,703,784 | Implications of Antipsychotic Use: Antipsychotic-Induced Movement Disorders, with a Focus on Tardive Dyskinesia. | Nurs Clin North Am | 2019 | https://conductscience.org/library/papers/31703784 | PubMed |
| 10 | 9,619,146 | Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome. | Am J Psychiatry | 1998 | https://conductscience.org/library/papers/9619146 | PubMed |
| 11 | 28,889,207 | Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research. | Psychopharmacology (Berl) | 2017 | https://conductscience.org/library/papers/28889207 | PubMed |
| 12 | 19,617,654 | Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test. | J Physiol Pharmacol | 2009 | https://conductscience.org/library/papers/19617654 | PubMed |
| 13 | 10,807,680 | [(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptors. | Br J Pharmacol | 2000 | https://conductscience.org/library/papers/10807680 | PubMed |
| 14 | 27,322,406 | Comparative Protein Structure Modeling Using MODELLER. | Curr Protoc Bioinformatics | 2016 | https://conductscience.org/library/papers/27322406 | PubMed |
| 15 | 28,400,155 | Histaminergic gene polymorphisms associated with sedation in clozapine-treated patients. | Eur Neuropsychopharmacol | 2017 | https://conductscience.org/library/papers/28400155 | PubMed |
| 16 | 28,745,550 | Improvising 5-HT7R homology model for design of high affinity ligands: model validation with docking, embrace minimization, MM-GBSA, and molecular dynamic simulations. | J Biomol Struct Dyn | 2018 | https://conductscience.org/library/papers/28745550 | PubMed |
| 17 | 24,245,803 | New strategy for receptor-based pharmacophore query construction: a case study for 5-HT₇ receptor ligands. | J Chem Inf Model | 2013 | https://conductscience.org/library/papers/24245803 | PubMed |
| 18 | 21,449,915 | Animal models of schizophrenia. | Br J Pharmacol | 2011 | https://conductscience.org/library/papers/21449915 | PubMed |
| 19 | 22,893,011 | Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis. | Ann Intern Med | 2012 | https://conductscience.org/library/papers/22893011 | PubMed |
| 20 | 23,999,469 | Effects of imperatorin on nicotine-induced anxiety- and memory-related responses and oxidative stress in mice. | Physiol Behav | 2013 | https://conductscience.org/library/papers/23999469 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,376,479 | Recent advances in the synthesis of antidepressant derivatives: pharmacologic insights for mood disorders. | 3 Biotech | 2024 | https://conductscience.org/library/papers/39376479 | PubMed |
| 37,184,096 | Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds-synthesis, biological activity, and structural evaluation. | J Enzyme Inhib Med Chem | 2023 | https://conductscience.org/library/papers/37184096 | PubMed |
| 36,615,578 | Synthesis, Structural and Behavioral Studies of Indole Derivatives D2AAK5, D2AAK6 and D2AAK7 as Serotonin 5-HT1A and 5-HT2A Receptor Ligands. | Molecules | 2023 | https://conductscience.org/library/papers/36615578 | PubMed |
| 36,476,619 | Funnel metadynamics and behavioral studies reveal complex effect of D2AAK1 ligand on anxiety-like processes. | Sci Rep | 2022 | https://conductscience.org/library/papers/36476619 | PubMed |
| 36,235,029 | Synthesis, Docking Studies and Pharmacological Evaluation of Serotoninergic Ligands Containing a 5-Norbornene-2-Carboxamide Nucleus. | Molecules | 2022 | https://conductscience.org/library/papers/36235029 | PubMed |
| 34,194,566 | Actualities in immunological markers and electrochemical sensors for determination of dopamine and its metabolites in psychotic disorders (Review). | Exp Ther Med | 2021 | https://conductscience.org/library/papers/34194566 | PubMed |
| 32,652,312 | Recent advances in multitarget-directed ligands targeting G-protein-coupled receptors. | Drug Discov Today | 2020 | https://conductscience.org/library/papers/32652312 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HTR1A | 3,350 | PubTator's text mining | https://conductscience.org/library/genes/3350 | NCBI Gene |
| HTR2A | 3,356 | PubTator's text mining | https://conductscience.org/library/genes/3356 | NCBI Gene |
| HTR7 | 3,363 | PubTator's text mining | https://conductscience.org/library/genes/3363 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32102432
GET https://conductscience.org/api/papers/v1/32102432/references?page=2